NCT05944367View on ClinicalTrials.gov

The Use of Breath Volatile Organic Compounds in Early Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis

CompletedOBSERVATIONAL

Enrollment

5

Participants

Timeline

Start Date

October 13, 2021

Primary Completion Date

December 23, 2022

Study Completion Date

December 23, 2022

Conditions

Cystic Fibrosis

Trial Locations (1)

CB2 0AA

Royal Papworth Hospital, Cambridge

All Listed Sponsors

lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV